DOI: http://dx.doi.org/10.18203/issn.2454-5929.ijohns20171182

Role of usage of antibiotics in pharyngitis: a prospective study

M. Deepthi, K. Narsimloo

Abstract


Background: Antibiotic resistance is emerging as a global public health problem and is growing day by day in both developed and developing countries. This study aims at scientific investigation into the need for the use of antibiotics in cases of pharyngitis.

Methods: A prospective study of 2000 patients complaining of sore throat, randomly selected from outpatient department during 1 year period from August 2015 – 2016 .They were studied clinically and investigated for infectious etiology and the role of usage of antibiotics was analysed.  

Results: Among 2000 patients, 1840 patients were relieved of sorethroat with only symptomatic treatment. Antibiotics were given only in 160 patients (8%) as throat swab demonstrated bacterial growth. Most common organisms were Group A beta haemolytic Streptococci and E coli. Allergic pharyngitis and laryngo pharyngeal reflux disease constituted the important causes of sore throat among middle age groups (20-40 years) and elderly age groups (50-60 years) respectively.

Conclusions: Antibiotics should not be given to patients unless there is documentary evidence of bacterial infection. Most of the patients (92%) did not require antibiotic prescription, the illness was self-limiting in acute cases and patients who demonstrated allergic and laryngo-pharyngeal reflux etiology required symptomatic medication. Inadvertent use of antibiotics will lead to spread of resistance in the community; this will limit the usage of higher antibiotics for complicated cases and ICU patients. This highlights opportunity to enhance physician‘s awareness for reducing inadvertent use of antibiotics among adult pharyngitis patients and optimizing Antibiotic therapy usage.


Keywords


Antibiotics, Pharyngitis, Antibiotic resistance

Full Text:

PDF

References


Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data. 2002;328:1-32.

Snow V, Mottur-Pilson C, Cooper R, Hoffman J. Principles of appropriate antibiotic use for acute pharyngitis in adults. Ann Intern Med. 2001;134:506–8.

Nakhoul GN, Hicker J. Management of Adults with Acute Streptococcal Pharyngitis: Minimal Value for Backup Strep Testing and Overuse of Antibiotics. J Gen Intern Med. 2013;28(6):830–4.

Danchin MH, Curtis N, Carapetis JR, Nolan TM. Treatment of sore throat in light of the Cochrane verdict: is the jury still out? Med J Aust. 2002;177(9):512–5.

Fine AM, Nizet V, Mandl KD. Large-Scale Validation of the Centor and McIsaac Scores to Predict Group A Streptococcal Pharyngitis. Arch Intern Med. 2012;172(11):847-52.

McIsaac WJ, Goel V, To T, Low DE. The validity of a sore throat rule in family practice. CMAJ. 2000;163:811–5.

Ebell MH, Point-of-Care Guides. Am Family Phys. 2003;68:9378.

Gill JM, Fleischut P, Haas S, Pellini B, Crawford A, Nash DB. Use of Antibiotics for Adult Upper Respiratory Infections in Outpatient Settings: A National Ambulatory Network Study. Fam Med. 2006;38(5):349-54.

Esposito S, Esposito I, Leone S. Considerations of antibiotic therapy duration in community and hospital-acquired bacterial infections. J Antimicrob Chemother. 2012;67(11):2570-5.

Sanchez GV, Hicks LA. Acute Sinusitis and Pharyngitis as Inappropriate Indications for Antibiotic Use. Antimicrob Agents Chemother. 2014;58(6):3572.

Hall BG, Barlow M. Evolution of the serine β-lactamases: past, present and future. Drug Resist Updat. 2004;7:111-23.

Laxminarayan R, Malani A, Howard D, Smith DL. Extending the cure: policy responses to the growing threat of antibiotic resistance. Antibiotic effectiveness as a natural resource. Washington, DC: Resources for the future; 2007: 19-21.

Gilbert DN, Edwards JE Jr. Is there hope for the prevention of future antimicrobial shortages? Clin Infect Dis. 2002;35:215-6.

McDonald LC. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment. Clin Infect Dis. 2006;42(2):65-71.

Global action plan on antimicrobial resistance, WHA 67.25 in May 2014. Available at http://www.wpro.who.int/entity/drug_resistance/resources/global_action_plan_eng.pdf. Accessed on 09 January 2017.